| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 65V47O9NOP |
| InChI Key | LNXDUSQEXVQFGP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H31N3O3 |
| Molecular Weight | 373.5 |
| AlogP | 2.35 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 54.04 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 27.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Narcolepsy | 2 | D009290 | ClinicalTrials |
| Cognitive Dysfunction | 1 | D060825 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1394808-82-2 |
| ChEMBL | CHEMBL4297328 |
| DrugBank | DB14835 |
| FDA SRS | 65V47O9NOP |
| Guide to Pharmacology | 10232 |
| SureChEMBL | SCHEMBL12484542 |